Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Viridian Therapeutics, Inc.\DE | 3,445,813 | reported | 13 Sept 2024 | tx 10+2,729,295−27,858 |
| Jade Biosciences, Inc. | 855,047 | reported | 06 Oct 2025 | tx 2+2,188,173 |
| Galecto, Inc. | 37,313 | reported | 23 Mar 2026 | tx 5+8,750,313−8,713 |
| Spyre Therapeutics, Inc. | 25,000 | reported | 29 May 2025 | tx 5+862,076−3,435,480 |
| Zenas BioPharma, Inc. | 18,500 | reported | 10 Jun 2025 | tx 1+18,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Mar 2026 | GRANT_AWARD | Galecto, Inc. | 37,313 | 0.00 USD | deriv |
| 09 Feb 2026 | EXERCISE | Galecto, Inc. | 5,809,000 | 0.00 USD | |
| 09 Feb 2026 | EXERCISE | Galecto, Inc. | 2,904,000 | 0.00 USD | |
| 09 Feb 2026 | EXERCISE | Galecto, Inc. | 5,809 | 0.00 USD | deriv |
| 09 Feb 2026 | EXERCISE | Galecto, Inc. | 2,904 | 0.00 USD | deriv |
| 06 Oct 2025 | GRANT_AWARD | Jade Biosciences, Inc. | 1,333,126 | 9.14 USD | |
| 06 Oct 2025 | GRANT_AWARD | Jade Biosciences, Inc. | 855,047 | 9.14 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Zenas BioPharma, Inc. | 18,500 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Spyre Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Spyre Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 13 Sept 2024 | PURCHASE | Viridian Therapeutics, Inc.\DE | 1,600,000 | 18.75 USD | |
| 28 Mar 2024 | OTHER | Viridian Therapeutics, Inc.\DE | 5,859 | — | |
| 28 Mar 2024 | OTHER | Viridian Therapeutics, Inc.\DE | 5,859 | — | |
| 28 Mar 2024 | OTHER | Viridian Therapeutics, Inc.\DE | 21,999 | 0.00 USD | deriv |
| 28 Mar 2024 | OTHER | Viridian Therapeutics, Inc.\DE | 21,999 | 0.00 USD | deriv |
| 22 Jan 2024 | PURCHASE | Viridian Therapeutics, Inc.\DE | 476,190 | 21.00 USD | |
| 29 Dec 2023 | OTHER | Spyre Therapeutics, Inc. | 406,038 | 0.00 USD | |
| 29 Dec 2023 | OTHER | Spyre Therapeutics, Inc. | 406,038 | 0.00 USD | |
| 29 Dec 2023 | OTHER | Spyre Therapeutics, Inc. | 3,435,480 | 0.00 USD | |
| 27 Oct 2020 | OTHER | Viridian Therapeutics, Inc.\DE | 87,891 | — | |
| 27 Oct 2020 | OTHER | Viridian Therapeutics, Inc.\DE | 438,502 | — | |
| 27 Oct 2020 | OTHER | Viridian Therapeutics, Inc.\DE | 82,349 | — | deriv |
| 27 Oct 2020 | OTHER | Viridian Therapeutics, Inc.\DE | 16,505 | — | deriv |